Literature DB >> 2464438

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

F Rastinejad1, P J Polverini, N P Bouck.   

Abstract

An inhibitor has been identified in the conditioned medium of hamster cells and hamster-human hybrids that suppresses neovascularization in vivo in the rat cornea. Inhibitory activity was tightly linked to the presence of an active cancer suppressor gene in transformants and revertants, in segregating hybrids, and in temperature-limited transformants. It copurified with a approximately 140 kd glycoprotein. Polyclonal antiserum raised against the purified preparation recognized a 140 kd protein in conditioned medium and was able to adsorb out all antiangiogenic activity. These results define the control of the activity of an inhibitor of neovascularization as one function of the cancer suppressor gene active in BHK21/cl13 cells and simultaneously identify a new inhibitor of angiogenesis, a process vital to the growth of solid tumors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2464438     DOI: 10.1016/0092-8674(89)90238-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  86 in total

Review 1.  Angiogenic molecules and mechanisms in breast cancer.

Authors:  I Wu; M A Moses
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

Review 2.  Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors.

Authors:  H Malonne; I Langer; R Kiss; G Atassi
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

3.  A fragment of human TrpRS as a potent antagonist of ocular angiogenesis.

Authors:  Atsushi Otani; Bonnie M Slike; Michael I Dorrell; John Hood; Karen Kinder; Karla L Ewalt; David Cheresh; Paul Schimmel; Martin Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

4.  The role of the vascular phase in solid tumor growth: a historical review.

Authors:  D Ribatti; A Vacca; F Dammacco
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

Review 5.  Therapeutic inhibition of angiogenesis.

Authors:  Hua-Tang Zhang; Roy Bicknell
Journal:  Mol Biotechnol       Date:  2003-10       Impact factor: 2.695

Review 6.  Mathematical modeling of tumor-induced angiogenesis.

Authors:  Nikos V Mantzaris; Steve Webb; Hans G Othmer
Journal:  J Math Biol       Date:  2004-02-06       Impact factor: 2.259

7.  Regional control of tumor growth.

Authors:  Alexander Zaslavsky; Catherine Chen; Jenny Grillo; Kwan-Hyuck Baek; Lars Holmgren; Sam S Yoon; Judah Folkman; Sandra Ryeom
Journal:  Mol Cancer Res       Date:  2010-08-24       Impact factor: 5.852

8.  Transvaginal colour flow imaging: a possible new screening technique for ovarian cancer.

Authors:  T Bourne; S Campbell; C Steer; M I Whitehead; W P Collins
Journal:  BMJ       Date:  1989-12-02

9.  Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis.

Authors:  T Abe; K Okamura; M Ono; K Kohno; T Mori; S Hori; M Kuwano
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

10.  Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1.

Authors:  L A DiPietro; P J Polverini
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.